Age-varying association between statin use and incident Alzheimer's disease. - Wikidata - awgldk - TriplyDB

Age-varying association between statin use and incident Alzheimer's disease.

Age-varying association between statin use and incident Alzheimer's disease.

http://www.wikidata.org/entity/Q35223278

about

Statins, cognition, and dementia—systematic review and methodological commentary Cholesterol, statins, and dementia: what the cardiologist should know Alzheimer's disease and environmental exposure to lead: the epidemiologic evidence and potential role of epigenetics Possible modification of Alzheimer's disease by statins in midlife: interactions with genetic and non-genetic risk factors Statin use in giant cell arteritis: a retrospective study.Toward onset prevention of cognitive decline in adults with Down syndrome (the TOP-COG study): study protocol for a randomized controlled trial.Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis.Pleiotropic effects of the HMG-CoA reductase inhibitors Cholesterol-independent neuroprotective and neurotoxic activities of statins: perspectives for statin use in Alzheimer disease and other age-related neurodegenerative disorders Statins and memory loss: An Australian experience Statin Use, Incident Dementia and Alzheimer Disease in Elderly African Americans Restoration of dietary-fat induced blood-brain barrier dysfunction by anti-inflammatory lipid-modulating agents.Association studies of several cholesterol-related genes (ABCA1, CETP and LIPC) with serum lipids and risk of Alzheimer's disease.Dyslipidemia and the risk of Alzheimer's disease.Dyslipidemia and dementia: current epidemiology, genetic evidence, and mechanisms behind the associations.Problems and possible solutions for therapy with statins.KIF6 719Arg allele is associated with statin effects on cholesterol levels in amnestic mild cognitive impairment and Alzheimer's disease patients.Lipid lowering agents, cognitive decline, and dementia: the three-city study.Towards onset prevention of cognition decline in adults with Down syndrome (The TOP-COG study): A pilot randomised controlled trial Statins and cognitive decline in older adults with normal cognition or mild cognitive impairment.Early Statin Use and the Progression of Alzheimer Disease: A Total Population-Based Case-Control Study.Epidemiological findings of vascular risk factors in Alzheimer's disease: implications for therapeutic and preventive intervention.Modeling the dementia epidemic.Mechanisms and clinical evidence of the pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in central nervous system disorders: a comprehensive review.Statins in the prevention of dementia and Alzheimer's disease: a meta-analysis of observational studies and an assessment of confounding.Association Studies of Specific Cholesterol Related Genes (APOE, LPL, and CETP) with Lipid Profile and Memory Function: A Correlative Study Among Rural and Tribal Population of Dharmapuri District, India.Neurovascular and Cognitive failure in Alzheimer's Disease: Benefits of Cardiovascular Therapy.Sex and Race Differences in the Association Between Statin Use and the Incidence of Alzheimer Disease.LDL-lipids from patients with hypercholesterolaemia and Alzheimer's disease are inflammatory to microvascular endothelial cells: mitigation by statin intervention Can statins prevent dementia in older adults?Statins reduce amyloid β-peptide production by modulating amyloid precursor protein maturation and phosphorylation through a cholesterol-independent mechanism in cultured neurons.β-sitosterol inhibits high cholesterol-induced platelet β-amyloid release.The role of statins in both cognitive impairment and protection against dementia: a tale of two mechanisms.Long-term statin use and dementia risk in Taiwan.Use of statins and the risk of dementia and mild cognitive impairment: A systematic review and meta-analysis.Does atrial fibrillation cause cognitive decline and dementia?How statins could be evaluated successfully in clinical trials for Alzheimer's disease?Association of lectin-like oxidized low density lipoprotein receptor 1 (OLR1) polymorphisms with late-onset Alzheimer disease in Han Chinese.

P2860

Q26852778-A99DE088-8108-4C84-AC4B-3BBC0EF5C26C Q28081974-D575F4BC-D9D3-4785-AC9B-DC4A44967CF4 Q28394199-4D2043B4-1A1F-4D33-825D-F5E8C7C3CF01 Q30814231-5998A23E-E5D2-4563-9705-454BDDBCC4BB Q33576127-0E3E7740-E8FC-4462-9E7F-377C0A5507DB Q33770940-6B4A2203-3B74-4A2A-B453-D2A0C8829694 Q34411415-7B6E90F5-CCD6-4171-878B-FF97E5BB7FA0 Q34894749-38261B7D-A6EF-4C42-9CAA-2BAF0BE7D36D Q35087574-CA7989C2-8EA8-416E-842A-FC3B71D27B68 Q35273182-909CEB1F-607C-4B27-B8D7-3A725726B7C0 Q36351416-310C30A3-0DD0-4273-B5D8-01D45453F6D0 Q36380198-7ACAC8CB-6F05-4A66-9AFD-10371EE3F9FA Q36493774-96607A8D-8A6E-454B-BCE3-1A7ABEF07540 Q36587136-F01B8C8F-6F35-4756-B49F-DE50C611CDF4 Q36946758-6EBC6E13-7FD2-4A41-B4F5-7C973FF5FCF0 Q37007848-1AEFFEB0-FADC-45F3-86E3-A18DA6EBB6EE Q37064329-989F251F-1603-4801-863F-1A0E8BA42E78 Q37095998-8768AC72-B47A-4E13-BC28-00FCA4C83294 Q37139026-E445618F-6B98-4A9F-8182-F2E553D05324 Q37171311-127B621E-B7CB-4931-9BDC-83669A6BA81B Q37328707-3BC7C623-200E-49E8-8D1C-BCE734192328 Q37947688-4BDA54CB-A624-4637-A87F-9C1B826D70BE Q37954450-FB05160F-6206-43C9-A392-ECF441047E13 Q38020536-BC2C3363-C4A1-4DA6-9AE9-517862BB8691 Q38066159-DEE5B0D4-F0A3-4486-8E21-4E736D0EB0B8 Q38640748-24F1203A-F50F-482E-9E2A-72CF8BB6443C Q38781022-F9A258A3-1436-4554-8AD8-4DD5B2345A91 Q39109470-B88CB53B-6670-4DB0-9CA5-E3824FDD377B Q41374680-2590A2EB-BB56-4944-8C4A-BB1C5AF39A84 Q42962630-C70FF4CA-D8F4-4859-B5E5-44ED9A7085AD Q44519885-3AFD6708-9C32-4472-BCF4-3186350250C7 Q48863807-A00C8CD6-25E9-482C-B8E1-F272D20421CA Q50532477-088739C8-0069-4D6D-A599-FDBB4C3E44D2 Q50657607-69F6854B-EE51-4CA6-9CF2-DAB146A8F5A6 Q52317633-B7F94B1B-DE0E-4DBB-85E1-22FEDC96B6F3 Q52687544-2C297BAC-8234-403F-8975-2CD050383E6F Q53328033-BBF08949-E770-43AA-89C2-2CFA394BBAA8 Q55378706-9359A804-FCE3-4F47-85D9-E697CC4C6746

P2860

Age-varying association between statin use and incident Alzheimer's disease.

http://www.wikidata.org/entity/Q35223278

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Age-varying association between statin use and incident Alzheimer's disease.

@ast

Age-varying association between statin use and incident Alzheimer's disease.

@en

type

label

Age-varying association between statin use and incident Alzheimer's disease.

@ast

Age-varying association between statin use and incident Alzheimer's disease.

@en

prefLabel

Age-varying association between statin use and incident Alzheimer's disease.

@ast

Age-varying association between statin use and incident Alzheimer's disease.

@en

P1433

Q35223278-DD4CC56C-65AE-4729-87DB-655FF6DC43DA

P1476

Q35223278-FB4B506B-737D-41B3-AAFA-AE7778CF6AAD

P2093

Q35223278-1F43E60C-B053-4745-B387-A25C82FA57F3

Q35223278-3357E188-688E-429A-8F42-47AAB04D3355

Q35223278-68FC6E3E-5D68-43D6-B7D2-1900DE2C4563

Q35223278-73395E39-89B5-4C16-9779-E3BBBD64182B

Q35223278-9CF5CA64-7266-406C-B8BD-14B21C5BDC87

Q35223278-A16F46C5-5C89-43C2-B82D-5C7EA28536B1

Q35223278-D62F8091-F24E-4F27-997B-329347325ED7

Q35223278-EAA4603D-CAE4-489D-8BD0-41A5370AC915

Q35223278-EB86C92E-1537-4872-BC13-FA15D5CACC18

P2860

Q35223278-102C0B56-BB05-482C-9568-54E9C019D908

Q35223278-1554FACF-52E6-47FE-B598-7C83530E850F

Q35223278-157DF640-ADD9-4569-BEAF-346649264461

Q35223278-22F5226E-7D6E-4436-A2F0-9E5D5143D164

Q35223278-29E6F818-1C78-4CF5-BB5A-C9AEE878D247

Q35223278-2FCF47F0-BF8A-474C-A442-82B9F2EAF8D0

Q35223278-3D510503-BCE1-4A7E-AC55-6F61E92139EF

Q35223278-45BA97B5-8CA1-4309-88F3-C244C8BB1550

Q35223278-4D6FC819-CEB9-4C75-A13E-7B6DF69E36D5

Q35223278-5D199780-5811-45C7-9110-8E76C68EA20C

P304

Q35223278-FECB6CC2-4720-4CF4-825B-CFC16B923109

P31

Q35223278-F655A21D-2CBD-4E30-B989-1658587FD9F7

P356

Q35223278-2E26DA79-A8DD-4C27-808F-27CA27376F92

P407

Q35223278-FC76080D-08B4-4B2F-8B72-35AF194B030C

P433

Q35223278-E18214D3-F303-4848-ABD7-AF050A8B7F7A

P478

Q35223278-A360B1FC-6FE8-4620-8ACC-D141F055DFA0

P50

Q35223278-151EDBBF-219C-4164-BCC8-447B5280D1CE

Q35223278-FDE235E0-DBC8-4287-9CB6-0D1DE2F1DECA

P577

Q35223278-877AE7FB-A07A-4F77-92EF-5B8960E4877C

P5875

Q35223278-1F9550DC-AA59-43ED-9842-0D6AC0151E5D

P698

Q35223278-557DE5C6-9AD4-4940-80F1-C6C5E6D2FDD3

P921

Q35223278-0DA7B5EB-DD92-4BB6-A098-5A6DDD005AF7

P932

Q35223278-7FF070AF-629A-4451-BA80-085F569B5325

P356

J.1532-5415.2010.02906.X

P1433

Journal of the American Geriatrics Society

P1476

Age-varying association between statin use and incident Alzheimer's disease.

@en

P2093

Elaine R Peskind

http://www.w3.org/2001/XMLSchema#string

Eric B Larson

http://www.w3.org/2001/XMLSchema#string

Ge Li

http://www.w3.org/2001/XMLSchema#string

Gerard D Schellenberg

http://www.w3.org/2001/XMLSchema#string

Isaac C Rhew

http://www.w3.org/2001/XMLSchema#string

James D Bowen

http://www.w3.org/2001/XMLSchema#string

Jane B Shofer

http://www.w3.org/2001/XMLSchema#string

John C S Breitner

http://www.w3.org/2001/XMLSchema#string

Wayne McCormick

http://www.w3.org/2001/XMLSchema#string

P2860

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

Time-dependent covariates in the Cox proportional-hazards regression model.

The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia.

Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results.

Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease.

Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study

Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26-week randomized, placebo-controlled, double-blind trial.

P304

1311-1317

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1532-5415.2010.02906.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

58

http://www.w3.org/2001/XMLSchema#string

P50

Walter A. Kukull

P577

2010-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44659600

http://www.w3.org/2001/XMLSchema#string

P698

20533968

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3176730

http://www.w3.org/2001/XMLSchema#string